Frenova Empowers Investigators and Research Teams
Why Frenova? As a Fresenius Medical Care company, Frenova manages the world’s largest network of renal research assets: over 550…
Increase Revenue and Give Patients More Options With Clinical Trials: Five Things to Consider When Adding or Expanding Research at Your Practice
Adding clinical research is a business strategy that, if approached knowledgably, can be of great benefit to physicians and medical…
How Do You Keep Your Trials Moving Forward When Patients Can’t Come to Your Office? FRENOVA KNOWS
Learn how Frenova is helping sites continue clinical research during the COVID-19 pandemic.
How Do You Keep Studies Progressing When All Signs Point to Stop? FRENOVA KNOWS
Learn what Frenova has been doing to keep studies on track during the COVID-19 pandemic.
Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Equipping Small Sites to Manage Trial Finances: Challenges and Solutions
Many clinical research sites today, although efficient in the actual conduct of research, have a lack of experience and resources…
Start with the Patient in Mind – Interview With Patient Partner Donnie King
Start with the patient in mind — let’s renew our resolve to represent those who participate in studies to advance…
Frenova Helps With Business, Allows Principal Investigator to Focus on Care
Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time…